FDG-PET vs. Histologic Staging of the Mediastinum in Patients With Pathologic N0-1 Non-small Cell Lung Cancer (NSCLC): What Should Be the Gold Standard?

Basit Öğe Kaydı
dc.contributor.authorXie, L.
dc.contributor.authorSaynak, M.
dc.contributor.authorChiu, W.
dc.contributor.authorBailey, J. E.
dc.contributor.authorFried, D. V.
dc.contributor.authorVeeramachaneni, N. K.
dc.contributor.authorHubbs, J. L.
dc.date.accessioned2024-06-12T11:23:57Z
dc.date.available2024-06-12T11:23:57Z
dc.date.issued2010
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS512en_US
dc.identifier.issn1556-0864
dc.identifier.issue12en_US
dc.identifier.startpageS511en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26737
dc.identifier.volume5en_US
dc.identifier.wosWOS:000284994100028en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleFDG-PET vs. Histologic Staging of the Mediastinum in Patients With Pathologic N0-1 Non-small Cell Lung Cancer (NSCLC): What Should Be the Gold Standard?en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu